Laboratorio Farmaceutico Erfo S.p.A. (BIT:ERFO)

Italy · Delayed Price · Currency is EUR

1.155

-0.020 (-1.70%)

Last updated: Aug 18, 2026, 10:58 AM CET

BIT:ERFO Financials Overview

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	9.73	9.73	6.03	5.93	4.72	5.01
Revenue Growth	23.21%	61.32%	1.69%	25.70%	-5.74%	24.09%
Gross Profit	3.7	3.7	2.54	2.6	2.45	2.77
Operating Income	1.07	1.07	0.52	0.84	0.99	1.58
Net Income	0.74	0.74	0.35	0.59	0.72	1.17
Earnings Per Share	0.09	0.09	0.04	0.07	0.08	0.78
EPS Growth	97.38%	110.31%	-40.08%	-13.73%	-89.76%	-

Revenue by Segment

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Network	7.86	7.86	4.62	4.74	3.95	4.13
Direct	1.09	1.09	0.85	0.7	0.5	0.6
Medical	0.41	0.41	0.31	0.24	0.12	0.05
Other	0.67	0.67	0.56	0.58	0.46	0.34
Total	10.03	10.03	6.34	6.26	5.03	5.13

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	1.05	1.05	0.38	0.84	1.47	0.37
Total Debt	1.35	1.35	0.38	0.47	0.58	0.74
Net Cash (Debt)	-0.3	-0.3	-0.01	0.38	0.89	-0.37
Net Cash Growth	-	-	-	-57.46%	-	-
Net Cash Per Share	-0.03	-0.03	-0.00	0.04	0.10	-0.25

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	0.92	0.92	1.24	1.3	0.76	2.27
Capital Expenditures	-0.07	-0.07	-0.07	-0.31	-0.46	-0.18
Free Cash Flow	0.85	0.85	1.17	0.98	0.3	2.1
Free Cash Flow Growth	-18.22%	-27.60%	19.38%	226.09%	-85.61%	59.61%

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	37.97%	37.97%	42.07%	43.84%	51.91%	55.26%
Operating Margin	10.96%	10.96%	8.68%	14.11%	20.91%	31.56%
Pretax Margin	10.71%	10.71%	8.72%	13.74%	20.10%	31.07%
Profit Margin	7.57%	7.57%	5.85%	9.95%	15.17%	23.29%
FCF Margin	8.74%	8.74%	19.46%	16.58%	6.39%	41.87%

Dividends

Fiscal Year	FY 2023
Period Ending	Dec '23 Dec 31, 2023
Dividend Per Share	0.060
Dividend Per Share Growth	-
Dividend Yield	4.85%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 18, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	13.58	17.00	30.61	19.97	25.51	-
Forward PE	-	12.78	19.46	13.10	12.30	-
P/FCF Ratio	11.78	14.74	9.20	11.99	60.57	-
PS Ratio	1.03	1.29	1.79	1.99	3.87	-